Article thumbnail

Checkpoint inhibitors in endometrial cancer: Preclinical rationale and clinical activity

By Gloria Mittica, Eleonora Ghisoni, Gaia Giannone, Massimo Aglietta, Sofia Genta and Giorgio Valabrega
Topics: Endometrial cancer; Immunotherapy; Microsatellite instability (MSI); Polymerase epsilon (POLE)-ultra-mutated; Tumor infiltrating lymphocytes (TILs); Oncology
Publisher: 'Impact Journals, LLC'
Year: 2017
DOI identifier: 10.18632/oncotarget.20042
OAI identifier: oai:iris.unito.it:2318/1663861

Suggested articles


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.